IPG Photonics Shares Plunge 8% on EU Patent Ruling
IPG Photonics shares fell 8% after the Unified Patent Court ruled its adjustable mode beam lasers infringe a Trumpf patent in seven European countries, affecting under 1% of sales. The company plans to appeal the decision and warned of increased regulatory and export control risks for its CROSSBOW counter-UAS.
1. Patent Infringement Ruling
The Unified Patent Court in Germany issued a ruling that IPG Photonics’ adjustable mode beam (AMB) laser designs infringe on a patent held by Trumpf SE & Co. KG. The decision covers certain AMB products sold in seven European countries, including Germany and France.
2. Sales Impact and Appeal
IPG Photonics estimates the ruling affects under 1% of its total annual sales and has announced plans to file an appeal. Management believes the decision creates uncertainty but expects to challenge the infringement finding at the court of appeal.
3. Regulatory and Export Risks
In the same notice, IPG Photonics flagged heightened regulatory scrutiny and export control risks for its CROSSBOW high-energy laser counter-UAS program. These risks could delay system development, limit international sales and increase compliance costs.
4. Market Reaction
Following the court ruling, IPG Photonics’ stock declined by 8% in the afternoon session. Investors weighed the legal setback and export-control concerns against the company’s broader revenue base and growth outlook.